Molecular Imaging

Amyloid PET scans validated in racially diverse patients

By Will Morton

Changes in care plans occurred in 59% of individuals after PET scans.

August 1, 2025

SNMMI highlights radioimmunotherapy study

By AuntMinnie.com staff writers

The study lays the foundation for development of radionuclide therapies targeting cancer stem cells.

July 30, 2025

Siemens reports revenue uptick in Q3

By AuntMinnie.com staff writers

The company reported a revenue increase of 7.6% over the same period last year.

July 30, 2025

GE HealthCare posts revenue increase in Q2

By AuntMinnie.com staff writers

The company reported a 3% increase in revenue in its second quarter of 2025.

July 30, 2025

Visual reads of amyloid PET scans effective in real-world settings

By Will Morton

The findings support the use of amyloid PET scans as acquired and visually read in the real world.

July 28, 2025

Shimadzu gets FDA authorization for head and breast PET scanner

By AuntMinnie.com staff writers

Shimadzu has obtained U.S. Food and Drug Administration (FDA) premarketing authorization for its PositView SET-5002 PET system.

July 25, 2025

Brain PET tracer delivered intranasally for first time in humans

By Will Morton

The study confirms the safety and efficacy of Ga-68 NOTA-insulin as a PET radiotracer that can be used for human neuroimaging.

July 24, 2025

Lantheus completes Life Molecular Imaging acquisition

By AuntMinnie.com staff writers

Life Molecular Imaging's CEO Ludger Dinkelborg, PhD, will become head of research and development for Lantheus.

July 22, 2025

PET/CT scans show lung damage in stone workers

By Will Morton

The metabolic activities occurring in the lungs of these patients have been unknown.

July 18, 2025

GT Medical Technologies secures $53M in funding

By AuntMinnie.com staff writers

Medical device developer GT Medical Technologies has secured $53 million in financing.

July 15, 2025

Nuclidium secures $98M in Series B funding

By AuntMinnie.com staff writers

The company plans to use the funding to advance clinical development of its copper-61 (Cu-61)/copper-67 (Cu-67) theranostic pipeline.

July 14, 2025

CereMark launches phase III PET tracer trial

By AuntMinnie.com staff writers

F-18 flornaptitril binds to both brain tau aggregates and beta-amyloid plaques simultaneously within a single PET scan.

July 10, 2025

Page 1 of 610

Next Page